Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1989-5-31
|
pubmed:abstractText |
While some advances have occurred in the maintenance treatment of unipolar depression, empirical data on recurrences of illness following the discontinuation of medication are sparse. We examined survival time during the first 18 months after discontinuation of medication in 74 patients with recurrent unipolar depression. Although demographic characteristics, clinical characteristics, and pharmacologic treatment variables failed to predict time to recurrence, continued interpersonal psychotherapy was significantly related to longer survival time.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0003-990X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
397-400
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2653267-Adult,
pubmed-meshheading:2653267-Clinical Trials as Topic,
pubmed-meshheading:2653267-Depressive Disorder,
pubmed-meshheading:2653267-Female,
pubmed-meshheading:2653267-Follow-Up Studies,
pubmed-meshheading:2653267-Humans,
pubmed-meshheading:2653267-Imipramine,
pubmed-meshheading:2653267-Male,
pubmed-meshheading:2653267-Outcome and Process Assessment (Health Care),
pubmed-meshheading:2653267-Personality Inventory,
pubmed-meshheading:2653267-Psychiatric Status Rating Scales,
pubmed-meshheading:2653267-Psychotherapy,
pubmed-meshheading:2653267-Recurrence,
pubmed-meshheading:2653267-Time Factors
|
pubmed:year |
1989
|
pubmed:articleTitle |
Early recurrence in unipolar depression.
|
pubmed:affiliation |
Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, PA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|